rs1427783096

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_013403.3(STRN4):​c.103T>C​(p.Ser35Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000036 in 1,305,522 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000068 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000040 ( 0 hom. )

Consequence

STRN4
NM_013403.3 missense

Scores

2
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.545

Publications

0 publications found
Variant links:
Genes affected
STRN4 (HGNC:15721): (striatin 4) Enables armadillo repeat domain binding activity and protein phosphatase 2A binding activity. Part of FAR/SIN/STRIPAK complex. [provided by Alliance of Genome Resources, Apr 2022]
FKRP (HGNC:17997): (fukutin related protein) This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008]
FKRP Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2I
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Ambry Genetics
  • muscular dystrophy-dystroglycanopathy type B5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
  • myopathy caused by variation in FKRP
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital muscular dystrophy with cerebellar involvement
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy without intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscle-eye-brain disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.124203384).
BS2
High AC in GnomAdExome4 at 46 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STRN4NM_013403.3 linkc.103T>C p.Ser35Pro missense_variant Exon 1 of 18 ENST00000263280.11 NP_037535.2 Q9NRL3-1
FKRPNM_024301.5 linkc.-253+238A>G intron_variant Intron 1 of 3 ENST00000318584.10 NP_077277.1 Q9H9S5A0A024R0R7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STRN4ENST00000263280.11 linkc.103T>C p.Ser35Pro missense_variant Exon 1 of 18 1 NM_013403.3 ENSP00000263280.4 Q9NRL3-1
FKRPENST00000318584.10 linkc.-253+238A>G intron_variant Intron 1 of 3 1 NM_024301.5 ENSP00000326570.4 Q9H9S5

Frequencies

GnomAD3 genomes
AF:
0.00000678
AC:
1
AN:
147564
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000203
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000397
AC:
46
AN:
1157958
Hom.:
0
Cov.:
34
AF XY:
0.0000302
AC XY:
17
AN XY:
563150
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22442
American (AMR)
AF:
0.00
AC:
0
AN:
8176
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14496
East Asian (EAS)
AF:
0.00181
AC:
45
AN:
24860
South Asian (SAS)
AF:
0.00
AC:
0
AN:
44650
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
26062
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3244
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
967796
Other (OTH)
AF:
0.0000216
AC:
1
AN:
46232
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.436
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000678
AC:
1
AN:
147564
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
71968
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40386
American (AMR)
AF:
0.00
AC:
0
AN:
14958
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3434
East Asian (EAS)
AF:
0.000203
AC:
1
AN:
4918
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4706
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9382
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
302
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66538
Other (OTH)
AF:
0.00
AC:
0
AN:
2042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 21, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.103T>C (p.S35P) alteration is located in exon 1 (coding exon 1) of the STRN4 gene. This alteration results from a T to C substitution at nucleotide position 103, causing the serine (S) at amino acid position 35 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.018
T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.012
N
LIST_S2
Benign
0.41
T;T
M_CAP
Pathogenic
0.74
D
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.34
N;N
PhyloP100
0.55
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
-0.33
N;N
REVEL
Benign
0.040
Sift
Benign
0.031
D;D
Sift4G
Benign
0.35
T;T
Polyphen
0.0
B;.
Vest4
0.12
MutPred
0.19
Loss of phosphorylation at S35 (P = 0.0088);Loss of phosphorylation at S35 (P = 0.0088);
MVP
0.26
MPC
0.94
ClinPred
0.23
T
GERP RS
0.75
PromoterAI
-0.042
Neutral
Varity_R
0.14
gMVP
0.18
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1427783096; hg19: chr19-47249585; API